Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription Articles published in J Neurochem Retrieve available abstracts of 123 articles: HTML format

Single Articles

October 2026
1. NICOL NI, Li T, Su Q, Suhocki A, et al
   AMPK Activator MK-8722 Improves Spatial Memory Deficit and Alters Metabolome in APP/PS1 AD Mouse Model.
   J Neurochem. 2026;170:e70563.
   PubMed     Abstract available
   
   
   September 2026
2. LIM D, Tapella L
   From Proteinopathy to Immunopathy in Alzheimer's Disease-A Role for Astrocytic Calcineurin?
   J Neurochem. 2026;170:e70543.
   PubMed    
   
   
   
3. PASSARELLA D, Russo C
   Rethinking gamma-Secretase Dysfunction in Alzheimer's Disease: From APP Processing to Network Perturbation.
   J Neurochem. 2026;170:e70550.
   PubMed    
   
   
   
4. 
   Correction to 'Exercise Snacking in Alzheimer's Disease: A Mechanistic Rationale Based on Repeated Exerkine Signaling'.
   J Neurochem. 2026;170:e70560.
   PubMed    
   
   
   July 2026
5. SOUSA RAL, Costa JMM, Pereira RRS, Vieira LCDR, et al
   Exercise Snacking in Alzheimer's Disease: A Mechanistic Rationale Based on Repeated Exerkine Signaling.
   J Neurochem. 2026;170:e70517.
   PubMed    
   
   
   
6. AKTAS E, Yurt I, Cerlet YN, Hanagasi HA, et al
   Rethinking Alzheimer's Disease Therapy: From Amyloid-Centric Approaches to Multi-Target Phytochemical Strategies.
   J Neurochem. 2026;170:e70506.
   PubMed     Abstract available
   
   
   
7. JAUREGUI GV, Coomes S, Emmett E, Thatcher A, et al
   APP/Abeta Signaling Orchestrates Reactive Astrocyte Networks in Alzheimer's Disease.
   J Neurochem. 2026;170:e70526.
   PubMed     Abstract available
   
   
   June 2026
8. RUTHIRAKUHAN M, Taha AY, Swardfager W
   Targeting Brain Cholesterol Homeostasis in Alzheimer's Disease: Mechanisms and Therapeutic Perspectives.
   J Neurochem. 2026;170:e70492.
   PubMed     Abstract available
   
   
   
9. DREW KL, Zorec R, Vardjan N, Kreft M, et al
   Brain Bioenergetics in Aging: Neurovascular and Neurometabolic Coupling and Fuels: 15th International Conference on Brain Energy Metabolism.
   J Neurochem. 2026;170:e70467.
   PubMed     Abstract available
   
   
   May 2026
10. WEBB-ROBINSON C, Murray H, Turner CP, Palpagama T, et al
    Insulin Receptor Isoform Pattern in Aged Normal and Alzheimer's Human Cortex.
    J Neurochem. 2026;170:e70455.
    PubMed     Abstract available
    
    
    
11. SHARMIN T, Doecke JD, Chatterjee P, Pedrini S, et al
    Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease.
    J Neurochem. 2026;170:e70436.
    PubMed     Abstract available
    
    
    
12. ARIYATH A, Arigo FD, Fyfe A, Fernando WMADB, et al
    A High-Throughput Assay for Monitoring and Quantifying Amyloid-beta Accumulation and Clearance in Alzheimer's Disease Cell Models.
    J Neurochem. 2026;170:e70473.
    PubMed     Abstract available
    
    
    April 2026
13. OLIVERA E, Saez A, Castro M, Garaventa P, et al
    A Decline in Metabotropic Glutamate mGlu3 Receptor Levels Is Associated With Amyloid Plaques in Alzheimer's Disease and Is Detectable in Serum During Mild Cognitive Impairment.
    J Neurochem. 2026;170:e70417.
    PubMed     Abstract available
    
    
    
14. MACIEL EMA, Silva NC, Santos LGP, Ribeiro FM, et al
    Advances in hiPSC-Derived Brain Organoids as a Model to Study Neuroinflammation in Alzheimer's Disease.
    J Neurochem. 2026;170:e70416.
    PubMed     Abstract available
    
    
    
15. PAIDI RK, Gorai S, Mondal S, Pahan K, et al
    L-Leucine Upregulates Lysosomal Biogenesis and Autophagy to Lower Plaques in 5XFAD Mouse Model of Alzheimer's Disease.
    J Neurochem. 2026;170:e70432.
    PubMed     Abstract available
    
    
    
16. WANG Y, Zhu J, Lizarazo S, Lee KY, et al
    E3 Ubiquitin Ligase Nedd4-2 Exacerbates Seizure-Induced Mitochondrial Defects in an Alzheimer's Disease Mouse Model.
    J Neurochem. 2026;170:e70440.
    PubMed     Abstract available
    
    
    
17. DURAN-ANIOTZ C, Pizarro M, Migeot J, Salazar-Londono S, et al
    Contextualizing Blood-Based Biomarkers for Dementia Globally.
    J Neurochem. 2026;170:e70443.
    PubMed     Abstract available
    
    
    February 2026
18. GIAMBARTOLOMEI GH, Iribarren P, Pasquini LA, Peluffo H, et al
    Microglia at the Forefront: New Insights From the Glial Club South Cone Meeting 2025.
    J Neurochem. 2026;170:e70384.
    PubMed     Abstract available
    
    
    
19. BARAL R, van Deventer R, Lyubchenko YL
    Amyloid beta-Cholesterol Interplay: Removal of Cholesterol From the Membranes to Catalyze Aggregation and Amyloid Pathology.
    J Neurochem. 2026;170:e70380.
    PubMed     Abstract available
    
    
    
20. RUANKHAM W, Prachayasittikul V, Pingaew R, Jeungprasopsuk W, et al
    Unraveling Network Pharmacology-Based Therapeutics of Anthranilate Sulfonamides via Sirtuins/FOXO3a Cascade in Alzheimer's Disease.
    J Neurochem. 2026;170:e70377.
    PubMed     Abstract available
    
    
    
21. GAO Z, Wang Y, Ren Y, Lyu J, et al
    Integrated Bioinformatics Analysis of Screen Mitochondrial Autophagy-Related Core Genes and Construct Diagnostic Model for Alzheimer's Disease.
    J Neurochem. 2026;170:e70387.
    PubMed     Abstract available
    
    
    December 2025
22. DULEWICZ M, Kac PR, Ortiz FG, Karikari TK, et al
    Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain-Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease.
    J Neurochem. 2025;169:e70313.
    PubMed     Abstract available
    
    
    
23. KOUTARAPU S, Roberts KF, Coyle RA, Mehla J, et al
    Post-Translational Modifications Distinguish Amyloid-beta Isoforms in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    J Neurochem. 2025;169:e70335.
    PubMed     Abstract available
    
    
    November 2025
24. BESCHORNER N, Xu Y, Jucker M, Ruiz-Riquelme A, et al
    Amyloid-beta Seeds in Alzheimer's Disease: Research Challenges and Implications.
    J Neurochem. 2025;169:e70267.
    PubMed     Abstract available
    
    
    
25. CONSTANTINO NJ, Ashley CC, Macauley SL
    The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks.
    J Neurochem. 2025;169:e70294.
    PubMed     Abstract available
    
    
    
26. PEREZ-RAMIREZ R, Cuchillo-Ibanez I, Sanchez-Romero R, Beltran-Sanahuja A, et al
    Development and Validation of an ICP-MS/MS Method for the Multielemental Analysis of Cerebrospinal Fluid, Examination of Alzheimer's Disease Samples.
    J Neurochem. 2025;169:e70307.
    PubMed     Abstract available
    
    
    October 2025
27. CHU X, Guo Y, Fu Y, Ren H, et al
    An Amino Acid and Carnitine Metabolite Profile for the Early Detection and Differential Diagnosis of Alzheimer's Disease.
    J Neurochem. 2025;169:e70234.
    PubMed     Abstract available
    
    
    
28. SANCHEZ DE MUNIAIN L, Escalada P, Ramirez MJ, Solas M, et al
    Astrocytes as Metabolic Sensors Orchestrating Energy-Driven Brain Vulnerability in Alzheimer's Disease.
    J Neurochem. 2025;169:e70252.
    PubMed     Abstract available
    
    
    September 2025
29. SMITH ED, Torrellas J, McKenna R, Vo Q, et al
    Acetylation Mimetic and Null Mutations Within the Filament Core of P301L Tau Have Varied Effects on Susceptibility to Seeding and Aggregation.
    J Neurochem. 2025;169:e70221.
    PubMed     Abstract available
    
    
    
30. MALARTE ML, Chiotis K, Ioannou K, Rodriguez-Vieitez E, et al
    Peripheral Inflammation Is Associated With Greater Neuronal Injury and Lower Episodic Memory Among Late Middle-Aged Adults.
    J Neurochem. 2025;169:e70222.
    PubMed     Abstract available
    
    
    
31. ZHAO J, Chen J, Lu J, Shi Q, et al
    Nitration of Tyrosine Residue Y10 of Abeta(1-42) Ameliorates Abeta(1-42)-Induced Neurotoxicity and Memory Impairment In Vitro and In Vivo.
    J Neurochem. 2025;169:e70218.
    PubMed     Abstract available
    
    
    August 2025
32. HARDY J
    Alzheimer's Disease: Treatment Challenges for the Future.
    J Neurochem. 2025;169:e70176.
    PubMed     Abstract available
    
    
    
33. SCHIFANI C, Anderson JAE, Nazeri A, Voineskos AN, et al
    In Vivo Cortical Microstructure: Relationships With Tauopathy and Cognitive Impairment in the Elderly.
    J Neurochem. 2025;169:e70167.
    PubMed     Abstract available
    
    
    
34. BUCCI M, Almkvist O, Bluma M, Ashton NJ, et al
    Profiling Plasma Biomarkers, Particularly pTau217 and pTau217/Abeta42, and Their Relation to Cognition in Memory Clinic Patients.
    J Neurochem. 2025;169:e70182.
    PubMed     Abstract available
    
    
    
35. TEIXEIRA LCR, Pereira JD, Mamede I, Caramelli P, et al
    Common miRNAs, Genes, and Regulatory Pathways in Alzheimer's Disease and Type 2 Diabetes Mellitus: An Integrative Analysis of Systematic Reviews, Bioinformatics and Data Mining.
    J Neurochem. 2025;169:e70196.
    PubMed     Abstract available
    
    
    
36. LI HY, Deng YT, Guo Y, Zhang Y, et al
    Clinical Utility of Plasma GFAP and NEFL as Biomarkers for Dementia in the Community.
    J Neurochem. 2025;169:e70210.
    PubMed     Abstract available
    
    
    
37. HAO Q, Fu Y, Zhao YL, Zhang ZQ, et al
    Association Between Phenoage With Cognitive Function and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology: The CABLE Study.
    J Neurochem. 2025;169:e70174.
    PubMed     Abstract available
    
    
    
38. DA CONCEICAO ARR, Marinatto J, Pinheiro LS, Rody T, et al
    The Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease.
    J Neurochem. 2025;169:e70209.
    PubMed     Abstract available
    
    
    
39. ESCAMILLA S, Perez-Gonzalez R, Marquez-Marco C, Camporesi E, et al
    Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders.
    J Neurochem. 2025;169:e70192.
    PubMed     Abstract available
    
    
    July 2025
40. HARDY J
    Milestone Review: The History of Molecular Genetics Analysis of Alzheimer's Disease.
    J Neurochem. 2025;169:e70148.
    PubMed     Abstract available
    
    
    
41. CHEN Y, Albert AL, Sehrawat A, Farinas MF, et al
    Equivalence of Plasma and Serum for Clinical Measurement of p-tau217: Comparative Analyses of Four Blood-Based Assays.
    J Neurochem. 2025;169:e70114.
    PubMed     Abstract available
    
    
    
42. HU S, Zhu P, Gao S, Wu S, et al
    Self-Report Alzheimer's Disease Statuses in UK Biobank Distort Downstream Analyses.
    J Neurochem. 2025;169:e70151.
    PubMed     Abstract available
    
    
    
43. BEZERRA IC, Dos Santos ERS, do Nascimento KGA, da Silva AJ, et al
    Label-Free Proteomic Profiling of the dvls2 (CL2006) Caenorhabditis elegans Alzheimer's Disease (AD) Model Reveals Conserved Molecular Signatures Shared With the Human AD Brain.
    J Neurochem. 2025;169:e70152.
    PubMed     Abstract available
    
    
    June 2025
44. LAU V, VanderZwaag J, Murray CJ, Tremblay ME, et al
    Exploring Iron Deposition Patterns Using Light and Electron Microscopy in the Mouse Brain Across Aging and Alzheimer's Disease Pathology Conditions.
    J Neurochem. 2025;169:e70086.
    PubMed     Abstract available
    
    
    
45. KOTOVA MM, Stewart AM, Grigoryan A, Shariff S, et al
    Towards Better and More Valid Zebrafish Models of Alzheimer's Disease: A Scientific Tribute to Prof. Mikhail I. Aghajanov.
    J Neurochem. 2025;169:e70090.
    PubMed     Abstract available
    
    
    May 2025
46. NAGAI-ARAKAWA I, Muramatsu I, Uwada J, Tsuda Y, et al
    Evaluation of the Alterations in Central Cholinergic Neurotransmission in Aging and Amyloid Precursor Protein Knock-In Mice.
    J Neurochem. 2025;169:e70081.
    PubMed     Abstract available
    
    
    April 2025
47. REHMAN AS, Tasleem A, Ali N, Khan R, et al
    Donepezil Improves PSD95 Expression, Mitigates Neuroinflammation via PI3K/Akt/NF-kappaB and Mitochondrial Dysfunction in a Rodent Model of Subarachnoid Haemorrhage.
    J Neurochem. 2025;169:e70063.
    PubMed     Abstract available
    
    
    March 2025
48. BONG SH, Choi H, Song HH, Kim DK, et al
    Metabolic Reprogramming in Primary Microglial Cell and Extracellular Vesicle Triggered by Abeta Exposure.
    J Neurochem. 2025;169:e70030.
    PubMed     Abstract available
    
    
    
49. YANG J, Pu YL, Pan QL, Wang L, et al
    CPNE7 Regulates Amyloidogenesis Through CAP1-Dependent ADAM10 Translation.
    J Neurochem. 2025;169:e70026.
    PubMed     Abstract available
    
    
    
50. AL-THANI NA, Stewart GS, Costello DA
    The Role of the Urea Cycle in the Alzheimer's Disease Brain.
    J Neurochem. 2025;169:e70033.
    PubMed     Abstract available
    
    
    
51. HEYLEN A, Vermeiren Y, De Deyn PP, Van Dam D, et al
    Monoaminergic Alterations at the Subregional Cervical and Thoracic Spinal Cord Level of Patients Within the FTD-ALS Continuum and Early-Onset AD: Low Thoracic Dopaminergic Activity in ALS.
    J Neurochem. 2025;169:e70046.
    PubMed     Abstract available
    
    
    
52. ALSHAEBI F, Sciortino A, Kayed R
    The Role of Glial Cell Senescence in Alzheimer's Disease.
    J Neurochem. 2025;169:e70051.
    PubMed     Abstract available
    
    
    February 2025
53. FU X, Quan S, Liang W, Li Y, et al
    FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1.
    J Neurochem. 2025;169:e70011.
    PubMed     Abstract available
    
    
    
54. NOVACK GV, Galeano P, Defelipe LA, Campanelli L, et al
    The Supramolecular Architecture of Mitochondrial Complex I in the Rat Brain Is Altered by Alzheimer's-Like Cerebral Amyloidosis.
    J Neurochem. 2025;169:e70017.
    PubMed     Abstract available
    
    
    
55. DIVYA, Faruq M, Nazir SS, Kaushik P, et al
    Ganaxolone Reverses the Effect of Amyloid beta-Induced Neurotoxicity by Regulating the Liver X Receptor Expression in APP Transfected SH-SY5Y Cells and Murine Model of Alzheimer's Disease.
    J Neurochem. 2025;169:e70007.
    PubMed     Abstract available
    
    
    
56. TISI A, Scipioni L, Carozza G, Di Re L, et al
    Alterations of endocannabinoid signaling and microglia reactivity in the retinas of AD-like mice precede the onset of hippocampal beta-amyloid plaques.
    J Neurochem. 2025;169:e16256.
    PubMed     Abstract available
    
    
    
57. SHARMIN T, Chatterjee P, Doecke JD, Ashton NJ, et al
    Circulating medium- and long-chain acylcarnitines are associated with plasma P-tau181 in cognitively normal older adults.
    J Neurochem. 2025;169:10.
    PubMed     Abstract available
    
    
    January 2025
58. ELSWORTHY RJ, Finelli MJ, Aqattan S, Dunleavy C, et al
    Altered metabolic function induced by Abeta-oligomers and PSEN1 mutations in iPSC-derived astrocytes.
    J Neurochem. 2025;169:e16267.
    PubMed     Abstract available
    
    
    
59. MENG J, Lei P
    Testing cognitive normal for Alzheimer's disease prediction.
    J Neurochem. 2025;169:e16272.
    PubMed     Abstract available
    
    
    
60. TSERING W, de la Rosa A, Ruan IY, Philips JL, et al
    Preferential clustering of microglia and astrocytes around neuritic plaques during progression of Alzheimer's disease neuropathological changes.
    J Neurochem. 2025;169:e16275.
    PubMed     Abstract available
    
    
    
61. HE Y, Zhu P, Gao S, Wu S, et al
    Identification of Alzheimer's disease susceptibility genes by integrating eight human brain single-cell transcriptomes with genome-wide association studies.
    J Neurochem. 2025;169:e16276.
    PubMed     Abstract available
    
    
    
62. 
    EXPRESSION OF CONCERN: Potent Anti-amyloidogenic and Fibril-destabilizing Effects of Polyphenols In Vitro: Implications for the Prevention and Therapeutics of Alzheimer's Disease.
    J Neurochem. 2025;169:e16285.
    PubMed    
    
    
    
63. PFITZER J, Pinky PD, Perman S, Redmon E, et al
    Troriluzole rescues glutamatergic deficits, amyloid and tau pathology, and synaptic and memory impairments in 3xTg-AD mice.
    J Neurochem. 2025;169:e16215.
    PubMed     Abstract available
    
    
    
64. WANG YC, Huang LY, Guo HH, Liu M, et al
    Higher CSF sTREM2 attenuates APOE epsilon4-related risk for amyloid pathology in cognitively intact adults: The CABLE study.
    J Neurochem. 2025;169:e16273.
    PubMed     Abstract available
    
    
    
65. PAWLOSKY R, Demarest TG, King MT, Estrada D, et al
    Effect of Dietary Ketosis and Nicotinamide Riboside on Hippocampal Krebs Cycle Intermediates and Mitochondrial Energetics in a DNA Repair-Deficient 3xTg/POLbeta(+/-) Alzheimer Disease Mouse Model.
    J Neurochem. 2025;169:e16295.
    PubMed     Abstract available
    
    
    
66. ROHR D, Helfrich M, Horing M, Grosseruschkamp F, et al
    Unsaturated Fatty Acids Are Decreased in Abeta Plaques in Alzheimer's Disease.
    J Neurochem. 2025;169:e16306.
    PubMed     Abstract available
    
    
    November 2024
67. CHEN YH, Wang ZB, Liu XP, Mao ZQ, et al
    Elevated serum sodium is linked to increased amyloid-dependent tau pathology, neurodegeneration, and cognitive impairment in Alzheimer's disease.
    J Neurochem. 2024 Nov 6. doi: 10.1111/jnc.16257.
    PubMed     Abstract available
    
    
    October 2024
68. XU F, Wu S, Gao S, Li X, et al
    Causal association between insulin sensitivity index and Alzheimer's disease.
    J Neurochem. 2024 Oct 31. doi: 10.1111/jnc.16254.
    PubMed     Abstract available
    
    
    September 2024
69. MITIAS S, Schaffer N, Nair S, Hook C, et al
    ProSAAS is preferentially up-regulated during homeostatic scaling and reduces amyloid plaque burden in the 5xFAD mouse hippocampus.
    J Neurochem. 2024;168:3235-3249.
    PubMed     Abstract available
    
    
    
70. STROPE TA, Wilkins HM
    The reciprocal relationship between amyloid precursor protein and mitochondrial function.
    J Neurochem. 2024;168:2275-2284.
    PubMed     Abstract available
    
    
    
71. XIONG M, Dahlen A, Roshanbin S, Wik E, et al
    Antibody engagement with amyloid-beta does not inhibit [(11)C]PiB binding for PET imaging.
    J Neurochem. 2024;168:2601-2610.
    PubMed     Abstract available
    
    
    
72. MA LY, Song JH, Gao PY, Ou YN, et al
    Amyloid pathology mediates the associations between plasma fibrinogen and cognition in non-demented adults.
    J Neurochem. 2024;168:2532-2542.
    PubMed     Abstract available
    
    
    
73. LOGSDON AF, Foresi B, Hu SJ, Quah E, et al
    Perineuronal net deglycosylation associates with tauopathy-induced gliosis and neurodegeneration.
    J Neurochem. 2024;168:1923-1936.
    PubMed     Abstract available
    
    
    
74. AMONTREE M, Nelson M, Stefansson L, Pak D, et al
    Resveratrol differentially affects MMP-9 release from neurons and glia; implications for therapeutic efficacy.
    J Neurochem. 2024;168:1895-1908.
    PubMed     Abstract available
    
    
    July 2024
75. DEN HOEDT S, Crivelli SM, Dorst-Lagerwerf KY, Leijten FPJ, et al
    The effects of APOE4 and familial Alzheimer's disease mutations on free fatty acid profiles in mouse brain are age- and sex-dependent.
    J Neurochem. 2024 Jul 13. doi: 10.1111/jnc.16176.
    PubMed     Abstract available
    
    
    
76. HUANG HX, Inglese P, Tang J, Yagoubi R, et al
    Mass spectrometry imaging highlights dynamic patterns of lipid co-expression with Abeta plaques in mouse and human brains.
    J Neurochem. 2024;168:1193-1214.
    PubMed     Abstract available
    
    
    
77. VAN DEN BERG E, Kersten I, Brinkmalm G, Johansson K, et al
    Profiling amyloid-beta peptides as biomarkers for cerebral amyloid angiopathy.
    J Neurochem. 2024;168:1254-1264.
    PubMed     Abstract available
    
    
    June 2024
78. ISEI MO, Girardi PA, Rodwell-Bullock J, Nehrke K, et al
    Site-specific phosphorylation of tau impacts mitochondrial function and response to stressors.
    J Neurochem. 2024;168:1019-1029.
    PubMed     Abstract available
    
    
    May 2024
79. CHEN Y, Zeng X, Diaz JL, Sehrawat A, et al
    Effect of blood collection tube containing protease inhibitors on the pre-analytical stability of Alzheimer's disease plasma biomarkers.
    J Neurochem. 2024 May 30. doi: 10.1111/jnc.16130.
    PubMed     Abstract available
    
    
    April 2024
80. 
    The following article for this Special Issue was previously published and can be found in its respective issue online: "Detection of early Alzheimer's disease-like molecular alterations in a mouse model expressing human ApoE4".
    J Neurochem. 2024;168:e2.
    PubMed     Abstract available
    
    
    
81. KWAN KH, Soreq H
    EDITOR SPOTLIGHT: Interview with Cholinergic Mechanisms Special Issue Guest Editor Hermona Soreq.
    J Neurochem. 2024;168:331-333.
    PubMed     Abstract available
    
    
    March 2024
82. NETZAHUALCOYOTZI C, Santillan-Cigales JJ, Adalid-Peralta LV, Velasco I, et al
    Infiltration of immune cells to the brain and its relation to the pathogenesis of Alzheimer's and Parkinson's diseases.
    J Neurochem. 2024 Mar 29. doi: 10.1111/jnc.16106.
    PubMed     Abstract available
    
    
    
83. ZHANG JF, Fang ZT, Zhao JN, Liu GP, et al
    Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells.
    J Neurochem. 2024;168:288-302.
    PubMed     Abstract available
    
    
    February 2024
84. PEREIRA JD, Teixeira LCR, Mamede I, Alves MT, et al
    miRNAs in cerebrospinal fluid associated with Alzheimer's disease: A systematic review and pathway analysis using a data mining and machine learning approach.
    J Neurochem. 2024 Feb 23. doi: 10.1111/jnc.16060.
    PubMed     Abstract available
    
    
    
85. HANRIEDER J
    Lipid imaging of Alzheimer's disease pathology.
    J Neurochem. 2024 Feb 19. doi: 10.1111/jnc.16079.
    PubMed     Abstract available
    
    
    
86. FERNANDES T, Melo T, Conde T, Neves B, et al
    Mapping the lipidome in mitochondria-associated membranes (MAMs) in an in vitro model of Alzheimer's disease.
    J Neurochem. 2024 Feb 7. doi: 10.1111/jnc.16072.
    PubMed     Abstract available
    
    
    
87. LIANG Y, Deng MG, Jian Q, Liu M, et al
    Maternal history of Alzheimer's disease predisposes to altered serum cholesterol levels in adult offspring.
    J Neurochem. 2024 Feb 5. doi: 10.1111/jnc.16056.
    PubMed     Abstract available
    
    
    
88. SU M, Xuan E, Sun X, Pan G, et al
    Synaptic adhesion molecule protocadherin-gammaC5 mediates beta-amyloid-induced neuronal hyperactivity and cognitive deficits in Alzheimer's disease.
    J Neurochem. 2024 Feb 3. doi: 10.1111/jnc.16066.
    PubMed     Abstract available
    
    
    
89. FRANCIS JS, Nguyen Q, Markov V, Leone P, et al
    Over-expression of N-acetylaspartate synthase exacerbates pathological energetic deficit and accelerates cognitive decline in the 5xFAD mouse.
    J Neurochem. 2024;168:69-82.
    PubMed     Abstract available
    
    
    December 2023
90. SALCEDO C, Pozo Garcia V, Garcia-Adan B, Ameen AO, et al
    Increased glucose metabolism and impaired glutamate transport in human astrocytes are potential early triggers of abnormal extracellular glutamate accumulation in hiPSC-derived models of Alzheimer's disease.
    J Neurochem. 2023 Dec 8. doi: 10.1111/jnc.16014.
    PubMed     Abstract available
    
    
    
91. GAO PY, Ou YN, Huang YM, Wang ZB, et al
    Associations between liver function and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in non-demented adults: The CABLE study.
    J Neurochem. 2023 Dec 6. doi: 10.1111/jnc.16025.
    PubMed     Abstract available
    
    
    
92. HUANG SY, Zhang YR, Yang L, Li YZ, et al
    Circulating metabolites and risk of incident dementia: A prospective cohort study.
    J Neurochem. 2023;167:668-679.
    PubMed     Abstract available
    
    
    November 2023
93. QIN H, Zhou L, Haque FT, Martin-Jimenez C, et al
    Diverse signaling mechanisms and heterogeneity of astrocyte reactivity in Alzheimer's disease.
    J Neurochem. 2023 Nov 6. doi: 10.1111/jnc.16002.
    PubMed     Abstract available
    
    
    
94. HAMILTON K, Morrow K, Markantoni E, Harvey J, et al
    Leptin prevents aberrant targeting of tau to hippocampal synapses via PI 3 kinase driven inhibition of GSK3beta.
    J Neurochem. 2023;167:520-537.
    PubMed     Abstract available
    
    
    October 2023
95. FURMAN S, Green K, Lane TE
    COVID-19 and the impact on Alzheimer's disease pathology.
    J Neurochem. 2023 Oct 18. doi: 10.1111/jnc.15985.
    PubMed     Abstract available
    
    
    
96. TURNER AJ
    Book Review: Alzheimer's Disease Research: What has guided research so far and why it is high time for a paradigm shift (Christian Behl. Springer Nature, Switzerland, 2023) 661 pp.
    J Neurochem. 2023 Oct 14. doi: 10.1111/jnc.15989.
    PubMed     Abstract available
    
    
    
97. SAMUELS JD, Lukens JR, Price RJ
    Emerging roles for ITAM and ITIM receptor signaling in microglial biology and Alzheimer's disease-related amyloidosis.
    J Neurochem. 2023 Oct 11. doi: 10.1111/jnc.15981.
    PubMed     Abstract available
    
    
    September 2023
98. WANG R, Lu KP, Zhou XZ
    Function and regulation of cis P-tau in the pathogenesis and treatment of conventional and nonconventional tauopathies.
    J Neurochem. 2023;166:904-914.
    PubMed     Abstract available
    
    
    
99. SAEZ-VALERO J, Perez-Gonzalez R
    BACE2 beyond beta-processing of APP, its neuroprotective role in cerebrovascular endothelium.
    J Neurochem. 2023;166:887-890.
    PubMed     Abstract available
    
    
    
100. CHENG JY, Deng YT, Yu JT
     The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.
     J Neurochem. 2023;166:972-981.
     PubMed     Abstract available
     
     
     August 2023
101. LAU SF, Fu AKY, Ip NY
     Receptor-ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology.
     J Neurochem. 2023 Aug 21. doi: 10.1111/jnc.15933.
     PubMed     Abstract available
     
     
     
102. CUENCA-BERMEJO L, Prinetti A, Kublickiene K, Raparelli V, et al
     Fundamental neurochemistry review: Old brain stories - Influence of age and sex on the neurodegeneration-associated lipid changes.
     J Neurochem. 2023;166:427-452.
     PubMed     Abstract available
     
     
     July 2023
103. WARTH PEREZ ARIAS CC, Silbern I, Caldi Gomes L, Wartmann H, et al
     Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease.
     J Neurochem. 2023 Jul 28. doi: 10.1111/jnc.15924.
     PubMed     Abstract available
     
     
     
104. RAI A, Ojiakor OA, Rylett RJ
     Detection of early Alzheimer's disease-like molecular alterations in a mouse model expressing human ApoE4.
     J Neurochem. 2023 Jul 6. doi: 10.1111/jnc.15904.
     PubMed     Abstract available
     
     
     
105. MOREIRA GG, Gomes CM
     Tau liquid-liquid phase separation is modulated by the Ca(2+) -switched chaperone activity of the S100B protein.
     J Neurochem. 2023;166:76-86.
     PubMed     Abstract available
     
     
     
106. MATAFORA V, Gorb A, Yang F, Noble W, et al
     Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Abeta.
     J Neurochem. 2023;166:346-366.
     PubMed     Abstract available
     
     
     
107. SECKER C, Motzny AY, Kostova S, Buntru A, et al
     The polyphenol EGCG directly targets intracellular amyloid-beta aggregates and promotes their lysosomal degradation.
     J Neurochem. 2023;166:294-317.
     PubMed     Abstract available
     
     
     
108. SANTIAGO TC, Parra L, Nani JV, Fidalgo TM, et al
     Angiotensin-converting enzymes as druggable features of psychiatric and neurodegenerative disorders.
     J Neurochem. 2023;166:138-155.
     PubMed     Abstract available
     
     
     June 2023
109. ANDERSON T, Sharma S, Kelberman MA, Ware C, et al
     Obesity during preclinical Alzheimer's disease development exacerbates brain metabolic decline.
     J Neurochem. 2023 Jun 30. doi: 10.1111/jnc.15900.
     PubMed     Abstract available
     
     
     
110. MAKSOUR S, Ooi L
     Innovations advancing our understanding of microglia in Alzheimer's disease: From in vitro to in vivo models.
     J Neurochem. 2023 Jun 15. doi: 10.1111/jnc.15885.
     PubMed     Abstract available
     
     
     
111. ZHAO Y, Zhou H, Zhao Y, Liang Z, et al
     BACE1 SUMOylation deregulates phosphorylation and ubiquitination in Alzheimer's disease pathology.
     J Neurochem. 2023 Jun 7. doi: 10.1111/jnc.15870.
     PubMed     Abstract available
     
     
     
112. HE RB, Li L, Liu LZ, Ma YJ, et al
     Ceftriaxone improves impairments in synaptic plasticity and cognitive behavior in APP/PS1 mouse model of Alzheimer's disease by inhibiting extrasynaptic NMDAR-STEP(61) signaling.
     J Neurochem. 2023 Jun 7. doi: 10.1111/jnc.15874.
     PubMed     Abstract available
     
     
     
113. BARINGER SL, Simpson IA, Connor JR
     Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation.
     J Neurochem. 2023;165:625-642.
     PubMed     Abstract available
     
     
     
114. GROVER S, Pham T, Jones A, Sinobas-Pereira C, et al
     A new class of monoclonal Abeta antibodies selectively targets and triggers deposition of Abeta protofibrils.
     J Neurochem. 2023;165:860-873.
     PubMed     Abstract available
     
     
     
115. DOHERTY G, Holiday A, Malekizadeh Y, Manolescu C, et al
     Leptin-based hexamers facilitate memory and prevent amyloid-driven AMPA receptor internalisation and neuronal degeneration.
     J Neurochem. 2023;165:809-826.
     PubMed     Abstract available
     
     
     May 2023
116. FLEEMAN RM, Kuhn MK, Chan DC, Proctor EA, et al
     Apolipoprotein E epsilon4 modulates astrocyte neuronal support functions in the presence of amyloid-beta.
     J Neurochem. 2023;165:536-549.
     PubMed     Abstract available
     
     
     April 2023
117. MOK KK, Yeung SH, Cheng GW, Ma IW, et al
     Apolipoprotein E epsilon4 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport.
     J Neurochem. 2023;165:55-75.
     PubMed     Abstract available
     
     
     March 2023
118. CARNA M, Novotny JS, Dragisic N, Slavik H, et al
     Missorting of Plasma miRNAs in Aging and Alzheimer's Disease.
     J Neurochem. 2023 Mar 9. doi: 10.1111/jnc.15801.
     PubMed     Abstract available
     
     
     
119. WENZEL TJ, Le J, He J, Alcorn J, et al
     Fundamental Neurochemistry Review: Incorporating a greater diversity of cell types, including microglia, in brain organoid cultures improves clinical translation.
     J Neurochem. 2023;164:560-582.
     PubMed     Abstract available
     
     
     
120. LOEFFLER DA
     Experimental approaches for altering the expression of Abeta-degrading enzymes.
     J Neurochem. 2023;164:725-763.
     PubMed     Abstract available
     
     
     
121. SUN Y, Islam S, Gao Y, Nakamura T, et al
     Apolipoprotein E4 inhibits gamma-secretase activity via binding to the gamma-secretase complex.
     J Neurochem. 2023;164:858-874.
     PubMed     Abstract available
     
     
     
122. TORTUYAUX R, Avila-Gutierrez K, Oudart M, Mazare N, et al
     Physiopathological changes of ferritin mRNA density and distribution in hippocampal astrocytes in the mouse brain.
     J Neurochem. 2023;164:847-857.
     PubMed     Abstract available
     
     
     February 2023
123. HOENIG MC, Drzezga A
     Clear-headed into old age: Resilience and resistance against brain aging-A PET imaging perspective.
     J Neurochem. 2023;164:325-345.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum